FDA Inspection
Pillar5 Pharma Inc.Pillar5 Pharma Inc. – FDA Inspection, Jun 5, 2026
Record Details
This FDA Inspection record concerns Pillar5 Pharma Inc., with an inspection on June 5, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 797a6a97-028e-475d-bd9f-5894cfb5abda
Inspection Facts
- Inspection number
- 1323174
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)(10)(v)Cleaning System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pillar5 Pharma Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| December 15, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 26, 2018 | VAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Pillar5 Pharma Inc.
- FDA Inspection 1261773 - 2025-02-07
- FDA Inspection 1226692 - 2023-12-15
- FDA Inspection 1119040 - 2020-02-21
- FDA Inspection 1058599 - 2018-05-17
- FDA Inspection 1038745 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.